Mostrar el registro sencillo del ítem
dc.contributor.author
Kristensen, Finn Børlum
dc.contributor.author
Husereau, Don
dc.contributor.author
Huic, Mirjana
dc.contributor.author
Drummond, Michael
dc.contributor.author
Bond, Kenneth
dc.contributor.author
Augustovski, Federico Ariel
dc.contributor.author
Booth, Andrew
dc.contributor.author
Bridges, John F.P.
dc.contributor.author
Grimshaw, Jeremy
dc.contributor.author
IJzerman, Maarten J.
dc.contributor.author
Jonsson, Egon
dc.contributor.author
Ollendorf, Daniel A.
dc.contributor.author
Rüther, Alric
dc.contributor.author
Siebert, Uwe
dc.contributor.author
Wailoo, Allan
dc.date.available
2021-11-30T14:42:37Z
dc.date.issued
2019-01
dc.identifier.citation
Kristensen, Finn Børlum; Husereau, Don; Huic, Mirjana; Drummond, Michael; Bond, Kenneth; et al.; Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA; Wiley Blackwell Publishing, Inc; Value In Health; 22; 1; 1-2019; 13-20
dc.identifier.issn
1098-3015
dc.identifier.uri
http://hdl.handle.net/11336/147733
dc.description.abstract
The systematic use of evidence to inform healthcare decisions, particularly health technology assessment (HTA), has gained increased recognition. HTA has become a standard policy tool for informing decision makers who must manage the entry and use of pharmaceuticals, medical devices, and other technologies (including complex interventions) within health systems, for example, through reimbursement and pricing. Despite increasing attention to HTA activities, there has been no attempt to comprehensively synthesize good practices or emerging good practices to support population-based decision-making in recent years. After the identification of some good practices through the release of the ISPOR Guidelines Index in 2013, the ISPOR HTA Council identified a need to more thoroughly review existing guidance. The purpose of this effort was to create a basis for capacity building, education, and improved consistency in approaches to HTA-informed decision-making. Our findings suggest that although many good practices have been developed in areas of assessment and some other key aspects of defining HTA processes, there are also many areas where good practices are lacking. This includes good practices in defining the organizational aspects of HTA, the use of deliberative processes, and measuring the impact of HTA. The extent to which these good practices are used and applied by HTA bodies is beyond the scope of this report, but may be of interest to future researchers.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Wiley Blackwell Publishing, Inc
dc.rights
info:eu-repo/semantics/restrictedAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
Health Technology Assessment
dc.subject.classification
Otras Ciencias de la Salud
dc.subject.classification
Ciencias de la Salud
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2021-01-04T14:31:49Z
dc.journal.volume
22
dc.journal.number
1
dc.journal.pagination
13-20
dc.journal.pais
Reino Unido
dc.journal.ciudad
Londres
dc.description.fil
Fil: Kristensen, Finn Børlum. Technical University of Denmark; Dinamarca
dc.description.fil
Fil: Husereau, Don. University of Ottawa; Canadá
dc.description.fil
Fil: Huic, Mirjana. Agency for Quality and Accreditation in Health Care and Social Welfare; Croacia
dc.description.fil
Fil: Drummond, Michael. University of York; Reino Unido
dc.description.fil
Fil: Bond, Kenneth. Canadian Agency for Drugs and Technologies in Health; Canadá
dc.description.fil
Fil: Augustovski, Federico Ariel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina
dc.description.fil
Fil: Booth, Andrew. University Of Sheffield; Reino Unido
dc.description.fil
Fil: Bridges, John F.P.. Ohio State University; Estados Unidos
dc.description.fil
Fil: Grimshaw, Jeremy. University of Ottawa; Canadá
dc.description.fil
Fil: IJzerman, Maarten J.. University of Melbourne; Australia
dc.description.fil
Fil: Jonsson, Egon. Institute Of Health Economics; Canadá
dc.description.fil
Fil: Ollendorf, Daniel A.. Tufts University; Estados Unidos
dc.description.fil
Fil: Rüther, Alric. Institut Für Qualität Und Wirtschaftlichkeit Im Gesundheitswesen; Alemania
dc.description.fil
Fil: Siebert, Uwe. Massachusetts General Hospital; Estados Unidos
dc.description.fil
Fil: Wailoo, Allan. University Of Sheffield; Reino Unido
dc.journal.title
Value In Health
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.jval.2018.08.010
Archivos asociados